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Abstract
Aims/hypothesis To directly assess the role of beta cell lipol-
ysis in insulin secretion and whole-body energy homeostasis,
inducible beta cell-specific adipose triglyceride lipase
(ATGL)-deficient (B-Atgl-KO) mice were studied under
normal diet (ND) and high-fat diet (HFD) conditions.
Methods Atglflox/flox mice were cross-bred withMip-Cre-ERT
mice to generateMip-Cre-ERT/+;Atglflox/flox mice. At 8 weeks
of age, these mice were injected with tamoxifen to induce
deletion of beta cell-specific Atgl (also known as Pnpla2),
and the mice were fed an ND or HFD.
Results ND-fed male B-Atgl-KO mice showed decreased
insulinaemia and glucose-induced insulin secretion (GSIS)
in vivo. Changes in GSIS correlated with the islet content of
long-chain saturated monoacylglycerol (MAG) species that
have been proposed to be metabolic coupling factors for insu-
lin secretion. Exogenous MAGs restored GSIS in B-Atgl-KO
islets. B-Atgl-KO male mice fed an HFD showed reduced
insulinaemia, glycaemia in the fasted and fed states and after
glucose challenge, as well as enhanced insulin sensitivity.
Moreover, decreased insulinaemia in B-Atgl-KO mice was
associated with increased energy expenditure, and lipid me-
tabolism in brown (BAT) and white (WAT) adipose tissues,
leading to reduced fat mass and body weight.
Conclusions/interpretation ATGL in beta cells regulates insu-
lin secretion via the production of signalling MAGs.
Decreased insulinaemia due to lowered GSIS protects
B-Atgl-KO mice from diet-induced obesity, improves insulin
sensitivity, increases lipid mobilisation from WAT and causes
BAT activation. The results support the concept that fuel ex-
cess can drive obesity and diabetes via hyperinsulinaemia, and
that an islet beta cell ATGL-lipolysis/adipose tissue axis con-
trols energy homeostasis and body weight via insulin
secretion.
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Introduction
In the aetiology of obesity-associated type 2 diabetes,
hyperinsulinaemia is generally seen as a compensatory mech-
anism for insulin resistance induced by overfeeding.
However, an alternative view is that fuel excess drives
hyperinsulinaemia, which in turn results in obesity, insulin
resistance followed by beta cell failure and diabetes [1–4].
Thus, reducing circulating insulin with diazoxide [5] or
through partial ablation of the pancreas-specific Ins1 gene
[6, 7] protects from high-fat diet (HFD)-induced obesity and
its associated complications. However, to our knowledge, it
has never been shown that a subtle change specifically in a
beta cell metabolic signalling pathway can modulate
insulinaemia, energy homeostasis, body weight gain and the
response to a high-energy diet.
Glucose and NEFA metabolism interface into the
glycerolipid/NEFA (GL/NEFA) cycle, with its lipogenesis
and lipolysis arms [8]. Lipolysis is mediated by the consecu-
tive actions of adipose triglyceride lipase (ATGL) [9],
catalysing the conversion of triacylglycerols (TGs) to diacyl-
glycerols (DAGs), hormone-sensitive lipase (HSL) [10],
hydrolysing DAG to monoacylglycerols (MAGs), and
monoacylglycerol lipase [11, 12] and α/β-hydrolase
domain-containing protein 6 (ABHD6) [13] hydrolysing
MAGs to NEFA and glycerol. Lipolysis generates lipid sig-
nalling molecules for glucose-stimulated insulin secretion
(GSIS) in beta cells [14], initial evidence coming from studies
showing inhibition of GSIS in rat islets by the pan-lipase in-
hibitor orlistat [15] or an HSL inhibitor [16]. Whole-body and
beta cell-specific HSL knockout (KO) mice showed a de-
creased insulin response to glucose in vivo and ex vivo [17,
18]. ATGL is the most abundant TG lipase in rat islets, and its
production is regulated by nutritional status [19]. Whole-body
Atgl (also known as Pnpla2) KO male mice are
hypoinsulinaemic and hypoglycaemic, and show increased
insulin sensitivity when fed a normal diet (ND) [19, 20] or
HFD [21], as well as altered GSIS in vivo and ex vivo [19].
Moreover, we have recently shown that lipolysis-derived
1-MAG is a metabolic coupling factor for GSIS [13],
confirming that beta cell lipolysis regulates GSIS.
In view of the importance of the GL/NEFA cycle in insulin
secretion and protection from glucolipotoxicity [11], and as
whole-body Atgl-KO mice show cardiomyopathy, TG
steatosis in various tissues and lower plasma levels of TG
and NEFA that influence insulin secretion, it is important to
understand the role of ATGL specifically in the beta cells in
the control of insulin secretion, in the protection of fuel
surplus toxicity in vivo and in the regulation of whole-body
energy homeostasis. Here we assessed the roles of beta cell
ATGL in ND- and HFD-fed mice using conditional beta cell-
specific Atgl-KO (B-Atgl-KO) mice.
Methods
Animals and metabolic in vivo studies
The breeding strategy is described in the electronic supple-
mentary material (ESM) Methods. At 8 weeks of age,
Atglflox/flox (fl/fl), Mip-Cre-ERT (MCre) and Mip-Cre-
ERT/+;Atglflox/flox mice received daily intraperitoneal injec-
tions of tamoxifen as described in ESM Methods and were
placed in individual cages. From 11 weeks of age, they were
fed an ND (15% fat by energy; Harlan Teklad, Madison, WI,
USA) or an HFD (Bio-Serv Diet no. F3282, 60% fat by ener-
gy; Frenchtown, NJ, USA) for 12 weeks. Body weight and
food intake were measured weekly. All procedures were
approved by the Institutional Committee for the Protection
of Animals at the Centre Hospitalier de l’Université de
Montréal.
Blood was collected between 08:00 and 10:00 hours in fed
or overnight-fasted mice. Plasma glucose, insulin, NEFA, TG,
glycerol and cholesterol were measured [17].
For the OGTTs, glucose (2 g/kg body weight) was admin-
istered orally in conscious mice at 09:00 hours after a 16 h
fast. For the insulin tolerance tests (ITTs), insulin (0.75 U/kg
body weight, Humulin; Lilly, Indianapolis, IN, USA) was
injected intraperitoneally in conscious mice at 14:00 hours
after 4 h of food withdrawal. OGTT and ITT were perfomed
blinded.
Mice were placed in metabolic cages (Comprehensive
Laboratory Animal Monitoring System, Columbus
Instruments; Columbus, OH, USA) individually, for 3 days
as previously described [22]. Metabolic mass was calculated
as previously proposed [23].
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Both male and female mice on a C57BL/6N background
were used in this study. All animals were housed individually
(after split in ND or HFD groups) at room temperature (23°C)
with a 12 h light/12 h dark cycle. Mice were randomly dis-
tributed in either ND or HFD groups.
Western blotting Proteins were extracted from isolated islets,
hypothalamic nuclei and adipose tissue, and membranes were
probed with antibodies against ATGL, phospho-HSL and total
HSL, tubulin and β-actin as described in ESM Methods.
Insulin secretion ex vivo Insulin secretion was measured in
isolated islets immediately after isolation as previously
described [24] with some modifications (see ESM Methods).
Islet metabolismMeasurement of lipolysis, glucose metabo-
lism and oxygen consumption rate is described in ESM
Methods.
Beta cell mass and pancreatic insulin content Beta cell
mass and pancreatic insulin content normalised by tissue
weight were assessed as previously described [13, 25].
Intracellular Ca2+Cytosolic Ca2+ was measured as previous-
ly described [24] with some modifications, detailed in ESM
Methods.
Targeted lipidomics GLs (MAGs, DAGs and TGs) were
quantified by LC-MS/MS on lipid extracts from 250 islets
incubated for 10 min in 3 or 16 mmol/l glucose as described
in ESM Methods.
Adipose tissue metabolism Lipolysis was measured on iso-
lated adipocytes from visceral (perigonadal; VC) and subcu-
taneous (inguinal; SC) adipose tissues and interscapular
brown adipose tissue (BAT) explants from 14-week-old male
mice on an HFD (fed state) as previously described [26] with
some modifications, detailed in ESM Methods.Fatty acid
oxidation was measured as previously described [22].
RNA extraction and RT-PCR Gene expression in adipose
tissue was assessed as previously described [19] with some
modifications (see ESM Methods and ESM Table 1).
Statistical analysis Results are expressed as mean ±SEM.
Statistical significance was calculated using the Student’s un-
paired two-tailed t test or one-way or two-way ANOVAwith
Bonferroni post hoc test for multiple comparisons, as indicat-
ed using GraphPad Prism software (version 6.0, San Diego,
CA, USA). A p value ≤0.05 was considered significant.
Results
Decreased insulinaemia and insulin response to glucose in
B-Atgl-KOmale mice on ND fl/fl mice were cross-bred with
MCre mice producing Cre recombinase specifically in beta
cells. The genotypes of the resulting offspring were
ascertained for both the Atgl gene and MCre transgene
(Fig. 1a). Eight-week-old Mip-Cre-ERT/Atgl-LoxP mice and
control mice (fl/fl and MCre mice) were treated with tamoxi-
fen to induce the deletion of the Atgl gene. Two weeks after
tamoxifen treatment, ATGL protein production was markedly
decreased (>90%) in islets from male B-Atgl-KO mice
(Fig. 1b). No change of ATGL level was observed in the
ventromedial hypothalamus (VMH) and arcuate nucleus
(ARC) (Fig. 1b) or in liver and adipose tissue (not shown),
indicating no leakage of Cre expression in these regions and
confirming the tissue specificity of MCre transgene expres-
sion [27, 28]. Glucose-stimulated lipolysis was markedly de-
creased in islets from male B-Atgl-KO mice (Fig. 1c,d).
Ten-week-old male B-Atgl-KO mice on a ND displayed a
modest but significant reduction in glycaemia only in the fed
state (Fig. 1e), and reduced insulinaemia by about 50%
(Fig. 1f) in both the fed and fasted states, when compared with
control mice. An OGTT revealed a trend towards glucose
intolerance (Fig. 1g) associated with reduced insulinaemia
(approximately 60%) in male B-Atgl-KO mice (Fig. 1h).
Body weight, pancreas weight, beta cell mass, insulin and
protein content per islet and plasma TG, NEFA and glycerol
were unchanged in B-Atgl-KO mice (ESM Table 2). Female
B-Atgl-KO mice showed no differences in glycaemia and
insulinaemia in fed and fasted states as well as during
OGTT, compared with controls (ESM Fig. 1).
Altered insulin secretion without changes in glucose
metabolism and Ca2+ response in isolated islets from
B-Atgl-KO islets Consistent with the altered insulin response
to glucose observed in vivo, GSIS was markedly reduced in
B-Atgl-KO islets, even though KCl-induced secretion was un-
changed (Fig. 2a).
We then examined whether altered energy metabolism or
calcium influx was contributing to the changes in insulin
secretion response in the B-Atgl-KO islets. Oxygen consump-
tion (coupled and uncoupled) (Fig. 2b) and glucose utilisation
and oxidation (Fig. 2c,d) were unaffected in B-Atgl-KO islets.
A similar rise in cytosolic Ca2+ levels in response to both
glucose and KCl was observed in B-Atgl-KO and control islet
cells (Fig. 2e,f). Thus, the altered GSIS observed in
B-Atgl-KO islets cannot be explained by changes in glucose
and mitochondrial metabolism or calcium influx.
Reduced levels of specific saturated long-chain MAG
species in B-Atgl-KO islets We previously provided evi-
dence that long-chain saturated 1-MAG species, in
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particular the relatively abundant 1-palmitoyglycerol (1-PG)
(16:0) and 1-stearoylglycerol (18:0), act as coupling fac-
tors for GSIS [13]. As lipolysis is decreased in B-Atgl-KO
islets, the formation of lipid signalling molecules such as
DAG or MAG, which regulate insulin secretion, might be
changed in these mice and affect GSIS. To address this, we
used a targeted lipidomics approach to measure different
GL species in isolated islets from fl/fl and B-Atgl-KO mice
following incubation at low or high glucose concentration.
As expected, total TG content was increased in B-Atgl-KO
islets compared with fl/fl islets (Fig. 3a). Despite an in-
crease at low glucose levels, total DAG content remained
unchanged in the B-Atgl-KO islets with high glucose levels
(Fig. 3b). Interestingly, 16:0 and 18:0 MAG species were
increased at high glucose levels in control but not in
B-Atgl-KO islets (Fig. 3c,d). We then examined whether
the addition of 1-PG could rescue insulin secretion in
B-Atgl-KO islets, showing that 1-PG was able to restore
GSIS in B-Atgl-KO islets to the same level as in fl/fl islets
without 1-PG. The extent of the increase in GSIS with
exogenous 1-PG was similar (around twofold) in both
B-Atgl-KO and fl/fl islets (Fig. 3e), even though the fl/fl
islets showed higher levels of GSIS.
Reduced body weight gain, insulin secretion and
glycaemia and improved insulin sensitivity in B-Atgl-KO
male mice fed an HFD Three weeks after tamoxifen treat-
ment, mice were fed with either an ND or an HFD for
12 weeks. ATGL protein was undetectable in islets from
23-week-old B-Atgl-KO mice fed an HFD, with unaltered
production in hypothalamic areas (Fig. 4a). Similar levels of
plasma cholesterol, TG, NEFA and glycerol were observed in
male and female B-Atgl-KO and control mice fed an HFD
(Table 1). As observed in ND-fed mice, GSIS was decreased
in B-Atgl-KO islets from male mice in the absence and pres-
ence of exogenous NEFA, whereas KCl-induced insulin
secretion was not affected (Fig. 4b).
After 8 weeks on an HFD, glycaemia and insulinaemia
were decreased in overnight-fasted and fed B-Atgl-KO male
mice (Table 1). Even if no change in glucose tolerance was
observed (Fig. 4c,d), plasma insulin levels were decreased
during an OGTT in HFD-fed male (Fig. 4e) and female
(Fig. 4f) KO mice. The reduced insulin secretion during
OGTT in B-Atgl-KO mice with unaltered glucose tolerance
suggests enhanced insulin sensitivity, which was confirmed
by ITT in HFD-fed male mice (Fig. 4g) but not in HFD-fed
female mice (Fig. 4h). B-Atgl-KO mice on an HFD showed










































































































































































Fig. 1 Reduced beta cell
lipolysis, fed and fasted
insulinaemia and GSIS in ND-fed
B-Atgl-KO (KO) male mice. (a)
Tail DNA from the offspring was
used to determine the presence of
the Mip-Cre transgene and to
distinguish between normal (+/+)
and homozygous (fl/fl) Atgl
alleles. (b) ATGL protein
production was measured by
western blotting in extracts from
isolated islets, VMH and ARC
from 10-week-fasted mice. (c, d)
Glycerol and NEFA released at 3
or 16mmol/l glucose (3G or 16G)
by isolated islets from fl/fl (black
bars) or KO (grey bars) mice
(n = 6 mice). Glycaemia and
insulinaemia in fl/fl (black
bars/circles), MCre (white
bars/triangles) and KO (grey
bars/squares) mice in fasted or fed
states (e, f) or during OGTT (g,
h). Insets depict AUC for
glycaemia and insulinaemia. Data
are mean ± SEM of 7–10 animals/
group. *p< 0.05, **p < 0.01,
***p< 0.001 vs fl/fl and
†p < 0.05, ††p< 0.01 vs MCre
(one-way ANOVA and
Bonferroni post hoc test)
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decreased body weight gain compared with controls, without
any change in food intake; this effect was already apparent
after 3 weeks on the HFD and was more pronounced in male
(Fig. 4i) than female (Fig. 4j) mice.
Increased energy expenditure and adipose tissue metabo-
lism in B-Atgl-KO male mice on an HFD To understand
how B-Atgl-KO mice are protected against diet-induced obe-
sity, we measured whole-body energy expenditure (EE) and
adipose tissue metabolism in HFD-fed male mice. As MCre
and fl/fl mice display a similar phenotype on an HFD and the
effects observed in B-Atgl-KO mice were less pronounced in
female than male mice, the rest of the experiments were car-
ried out only with male mice, using fl/flmice as a control. VC
and SC weight decreased in B-Atgl-KO mice compared with
fl/fl mice, while liver and BATweight did not differ (Fig. 5a).
After 48 h acclimatisation in metabolism cages, EE was mea-
sured in 14-week-old B-Atgl-KO mice that had been on an
HFD for only 3 weeks, before any significant change in body
weight had occurred. EE was increased in B-Atgl-KO mice
during the dark period without a change during the light peri-
od (Fig. 5b). As BAT plays a major role in the regulation of
whole-body EE, we measured BAT metabolism ex vivo.
Palmitate oxidation and lipolysis were higher in BATexplants
from B-Atgl-KO mice (Fig. 5c–e). Moreover, palmitate oxida-
tion was increased in VC (Fig. 5f) but not in SC (Fig. 5g) from
B-Atgl-KO mice, which could also contribute to the observed
enhanced EE in B-Atgl-KO (Fig. 5b).
As B-Atgl-KO mice displayed decreased insulinaemia and
since insulin inhibits lipolysis in white adipose tissue (WAT),
we then assessed whether basal and isoproterenol-stimulated
lipolysis were changed in isolated adipocytes from VC and
SC. Interestingly, isoproterenol-stimulated lipolysis and basal
NEFA release were increased in B-Atgl-KO adipocytes from
VC and SC (Fig. 5h–k). Levels of HSL Ser563 phosphoryla-
tion in VC and SC were consistently increased in overnight-
fasted B-Atgl-KO mice (Fig. 5l). Finally, an increased expres-
sion of genes involved in both lipolysis and lipogenesis path-
ways was observed in VC (Fig. 5m) but not in SC or BAT (not
shown) from B-Atgl-KO mice without changes in browning-
related gene expression, suggesting an increase in GL/NEFA
cycle activity in VC. Overall, the decreased body weight gain
observed in B-Atgl-KO mice can be explained by increased
whole-body EE, activation of BAT and VC and SC lipolysis
and fat oxidation, and enhanced futile (energy-consuming)































































































































16G Oligo FCCP Antim/Rot3G
Time (min)
Glucose KCl
Fig. 2 Reduced GSIS is not due to altered glucose and mitochondrial
metabolism or cytosolic Ca2+ in isolated islets from B-Atgl-KO (KO)
mice. (a) Insulin secretion in islets isolated from 10-week-old fl/fl (black
bars) or KO (grey bars) mice incubated for 20 min at 3 or 16 mmol/l
glucose (3G or 16G) and at 3 mmol/l glucose plus 35 mmol/l KCl (KCl)
(n= 5–7 mice). (b) Oxygen consumption rate (OCR) of isolated islets
from 10-week-old fl/fl (black circles) or KO (grey squares) mice at 3G
(basal condition) or 16G and after the addition of 5 μmol/l oligomycin
(Oligo), 1 μmol/l FCCP and 5 μmol/l rotenone/5 μmol/l antimycin
(Antim/Rot). Glucose utilisation (c) and oxidation (d) in isolated islets
from 10-week-old male mice at 3 and 16 mmol/l glucose (n = 6 mice).
Cytosolic Ca2+ at 3G (basal condition) or in response to 16G glucose (e)
or 35 mmol/l KCl (f) in dispersed islet cells (n= 5 mice). Data are mean
± SEM. **p< 0.01 vs fl/fl (Student’s t test)
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Discussion
The importance of ATGL as the major TG hydrolase during
lipolysis is well known, and we have previously provided
evidence indicating the regulatory role of lipolysis in beta cells
in insulin secretion regulation [14]. Even though the earlier
work showed that global deletion of ATGL affects whole-
body glucose and lipid metabolism [9, 10] and GSIS [19],
the specific role of beta cell ATGL and lipolysis in whole-
body energy homeostasis, insulin secretion and action, and
adipose tissue function is not known. Employing conditional
B-Atgl-KO mice, we now demonstrate that beta cell ATGL is
important in glucose signalling for insulin secretion via the
production of saturated long-chain 1-MAG, a lipid metabolic
coupling factor for the amplification of GSIS [13, 24]. Our
results also show that deletion of ATGL specifically in beta
cells is, by lowering insulin secretion response, able to protect
against HFD-induced hyperinsulinaemia, insulin resistance
and obesity, and also able to promote elevated EE by activat-
ing BAT, and lipolysis and fat oxidation in WAT.
Altered GSIS in B-Atgl-KO islets is associated with a de-
creased content of saturated MAG species and is restored by
exogenous 1-MAG, supporting the view that ATGL controls
the production of 1-MAG acting as a coupling factor for
GSIS. In contrast to a recent beta cell Atgl-KO study [29] that
will be discussed below, we did not find any evidence that
ATGL deletion in beta cells is associated with an alteration
in beta cell glucose and mitochondrial metabolism.
Addit ional ly, the glucose-induced Ca2+ rise and
KCl-induced insulin secretion were also unchanged in the
B-Atgl-KO islets. Thus, the reduction in GSIS in B-Atgl-KO
islets is not due to alterations in energy metabolism or Ca2+
signalling, but can be explained, at least in part, by a decreased
content of lipolysis-derived MAG species.
We noticed sex-dependent differences in insulin secretion
response to diet in the B-Atgl-KO mice. Thus, male, but not
female, B-Atgl-KO on the ND displayed reduced GSIS in vivo,
whereas both male and female B-Atgl-KO mice showed re-
duced GSIS with an HFD. This proves the general importance
of ATGL for GSIS, and the compensatory mechanisms involv-
ing other lipases (e.g. HSL and carboxylesterases) probably
override the consequences of ATGL deletion in female mice
on a ND.
In as much as Atgl deletion only in beta cells is able to
protect against obesity-associated complications, this study
brings out a new and previously unrecognised role for beta
cell ATGL and associated lipolysis-derived GSIS-promoting
signal(s) in the control of whole-body energy, insulin and
glucose homeostasis, and the development of obesity. Thus,
decreased insulinaemia in B-Atgl-KO male mice on an HFD
leads to increased EE, improved insulin sensitivity and
decreased body weight gain on an HFD via WAT fat
mobilisation and BAT activation (Fig. 6). Our results are in
line with studies showing that reducing circulating insulin
with diazoxide [5], partial ablation of the Ins1 gene [6, 7] or
the inhibition of insulin signalling by genetic or pharmacolog-
ical approaches [30, 31] protects from obesity and the meta-
bolic syndrome. In these studies, protection against diet-
induced obesity has been explained by increased EE due in
part to increased BAT activity and browning of WAT [6, 30,
31]. In the present study, we observed that increased lipolysis
in VC and SC is associated with increased HSL phosphoryla-
tion and also the production of different lipases in VC.
Interestingly, the levels of transcription factors and enzymes
involved in lipogenesis were also enhanced in the VC of
B-Atgl-KO male mice, suggesting an increase in futile
GL/NEFA cycling [11] coupled with enhanced NEFA
β-oxidation, which can also contribute to the increased EE
and protection against diet-induced obesity. Taken together,
these results support the concept that an islet beta cell
ATGL–lipolysis/adipose tissues axis controls energy homeo-
stasis and body weight via insulin secretion and insulinaemia.
The current results are at marked variance with a recent
study by Tang et al [29] that examined the consequences of























































































Fig. 3 Reduced glucose-induced rise in saturated MAG species and res-
toration of insulin secretion by exogenous MAG in B-Atgl-KO (KO)
islets. GL contents were measured in islets incubated for 10 min at 3 or
16mmol/l glucose and the results expressed as a percentage of the control
(3G fl/fl). (a) Total TG, (b) DAG, (c) MAG 16:0, and (d) MAG 18:0. (e)
Insulin secretion in islets isolated from fl/fl (black bars) or KO (grey bars)
incubated for 10 min at 3 or 16 mmol/l glucose ± 1-PG. Data are mean
± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs fl/fl and †p < 0.05;
††p< 0.01 3G vs 16G (Student’s t test)
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Table 1 Plasma variables of male and female mice fed an HFD
Variable Male mice Female mice
fl/fl MCre KO fl/fl MCre KO
Fed glycaemia (mmol/l) 8.5 ± 0.4 7.7 ± 0.4 6.9 ± 0.4 6.5 ± 0.7 6.3 ± 0.6 6.9 ± 0.8
Fasted glycaemia (mmol/l) 7.4 ± 0.5 7.5 ± 1 6.0 ± 0.5 5.1 ± 0.5 4.6 ± 1 4.2 ± 0.8
Fed insulinaemia (pmol/l) 774 ± 189 1210± 287 365 ± 48*†† 194 ± 29 361 ± 101 177 ± 63
Fasted insulinaemia (pmol/l) 120 ± 15 208 ± 30* 72 ± 10*†† 89± 25 108 ± 20 70 ± 8
Fasted TG (mmol/l) 0.37 ± 0.03 0.46± 0.06 0.40± 0.05 0.29 ± 0.02 0.44± 0.05* 0.26 ± 0.03†
Fasted NEFA (mmol/l) 0.47 ± 0.04 0.37± 0.05 0.45± 0.05 0.61 ± 0.05 0.50± 0.05 0.46 ± 0.08
Fasted glycerol (mmol/l) 0.15 ± 0.01 0.19± 0.03 0.15± 0.02 0.29 ± 0.01 0.36± 0.02* 0.29 ± 0.02
Fasted FC (mmol/l) 0.73 ± 0.08 0.95± 0.11 0.75± 0.09 0.29 ± 0.06 0.40± 0.05 0.26 ± 0.01
Fasted CE (mmol/l) 2.41 ± 0.23 2.8 ± 0.22 2.39± 0.21 1.34 ± 0.19 1.59± 0.15 1.21 ± 0.17
Body weight (g) 52.9 ± 0.8 50.43 ± 1.1 45.7 ± 1.5**† 33.4 ± 3.2 38.1 ± 1.6 31.8 ± 3.2
Data are means ± SEM for 6–8 male and 4–5 female mice
Cholesterol ester (CE), free cholesterol (FC), TG, NEFA and glycerol were measured in plasma from anaesthetised, overnight-fasted male mice at
23 weeks of age. Glycaemia and insulinaemia were determined in 17-week-old fed or 19-week-old overnight-fasted conscious mice. Body weight was
determined in 23-week-old mice
*p< 0.05, **p< 0.01 vs fl/fl; † p< 0.05, †† p < 0.01 vsMCre (one-way ANOVA and Bonferroni post hoc test)
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fl/fl KOMCre fl/fl KOMCre fl/fl KOMCre
Fig. 4 B-Atgl-KO (KO) male and female mice on HFD display reduced
GSIS and body weight (BW) gain. (a) ATGL protein production in ex-
tracts of isolated islets, VMH or ARC of 23-week-old male mice fed an
HFD. (b) Insulin secretion at 3 and 16 mmol/l glucose ± palmitate/oleate
(OP; 0.15 mmol/l each) (3G/OP and 16G/OP) and at 3 mmol/l glucose
plus 35 mmol/l KCl in isolated islets from 23-week-old male mice fed an
HFD (n = 4–5 mice). Glycaemia and insulinaemia during OGTTs in
19-week-old male (c, e) or female (d, f) mice: black bars/circles, fl/fl;
white bars/triangles, MCre; grey bars/squares, KO. Inset depicts AUC
for glycaemia and insulinaemia curves. Glycaemia during an ITT in
21-week-old male (g) or female (h) mice. Inset depicts area above the
curve (AAC). BW gain calculated relative to the weight prior to HFD
feeding in male (i) and female (j) mice. Inset shows average food intake
(FI). Data are mean ± SEM for 7–9 male and 4–5 female mice. *p < 0.05,
**p< 0.01, ***p< 0.001 vs fl/fl; †p< 0.05 and ††p< 0.01 vs MCre (one-
way or two-way ANOVA and Bonferroni post hoc test)
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under HFD conditions. Contrary to our results, the B-Atgl-KO
male mice Tang et al generated showed unchanged body
weight gain and insulin sensitivity, an almost total abolition
of GSIS in vivo, increased glycaemia in the fed state and
marked glucose intolerance. The isolated islets showed alter-
ations in oxygen consumption and mitochondrial function.
These discrepancies can be explained by three main differ-
ences between the two studies. First, the HFD model used is
different. In Tang et al’s paper, experiments were performed
on 8-week-old male mice with 4 weeks’HFD feeding directly
after weaning, a rarely used protocol, whereas we used
23-week-old mice with 12 weeks of HFD feeding from
11 weeks of age. The second difference is in the Cre
recombinase transgenic mice used to create the beta cell-
specific gene deletion. To avoid compensatory mechanisms
in vivo that can occur when a protein is deleted during devel-
opment, we used an inducible conditional Atgl-KO in adult
beta cells. In contrast, Tang et al mainly used Rip-Cre mice in
which ATGL is deleted during development. Third, the
B-Atgl-KO mice were bred from different C57BL/6 back-
grounds: C57BL/6N in our study vs C57BL/6J in Tang
et al’s study. Great concerns exist regarding the use of mice
on a C57BL/6J background for beta cell studies. Indeed, this
strain shows altered insulin secretion and expresses a mutation
in nicotinamide nucleotide transhydrogenase, an enzyme in-
volved in mitochondrial energy metabolism, NADPH produc-
tion and the regulation of GSIS [14, 25, 32, 33]. Overall, strain
background, the Cre-expressing mouse model (promoter and
age of deletion) and the HFD protocol can explain the discrep-
ancies observed between our results and those of Tang et al.
It has recently been shown that MCre mice express a hu-
man growth hormone (hGH) minigene in pancreatic islets,
and that local hGH secretion is associated with increased
insulin content and resistance to streptozotocin-induced
hyperglycaemia [34]. However, MCre mice exhibited normal
glycaemia, glucose tolerance and insulin sensitivity and
appropriate GSIS [34]. In our study, even if hGH is present
on the transgene construct used to generate the MCre mice
[28], it does not create a specific phenotype in MCre mice
compared with fl/fl mice for all the variables that we studied.
In summary, our results demonstrate that beta cell ATGL
regulates GSIS via the production of lipolysis-derived long-
chain saturated MAG, a metabolic coupling factor for insulin
secretion. Modulation of lipolysis in beta cells by ATGL reg-
ulates whole-body energy homeostasis in the context of met-
abolic stress, by preventing exacerbated insulin secretion.
Indeed, decreased insulinaemia leads to BAT activation and
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Fig. 5 Increased whole-body EE and activation of WAT and BAT in
B-Atgl-KO (KO) mice on an HFD. (a) Tissue weight of 23-week-old
fl/fl (black bars) and KO (grey bars) male mice fed an HFD. (b) EE
normalised by metabolic mass (met mass) in 14-week-old mice on an
HFD. Palmitate oxidation and glycerol and NEFA release from BAT
(c–e) Palmitate oxidation in VC (f) and SC (g); glycerol and NEFA
release from VC (h, i) and SC (j, k) in 14-week-old mice on an HFD.
Iso, Isoproterenol. (l) HSL phosphorylation on Ser563 in BAT, VC and
SC and (m) gene expression in VC in 23-week-old mice on an HFD. Data
are mean ± SEM for five mice. *p < 0.05, **p < 0.01, ***p < 0.001
(Student’s t test). Srebp1c is also known as Srebf1; Gpat is also known
as Gpam; Pgc1a is also known as Ppargc1a
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sensitivity and protect against HFD-induced obesity. These
results support the concept that fuel excess drives obesity
and diabetes via hyperinsulinaemia and provide an additional
impetus to lower insulin hypersecretion as a potential
therapeutic approach for obesity and diabetes.
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